Scientists Find RNA Molecule That Kills Breast Cancer Cells

Scientists at QIMR Berghofer in Australia have discovered an RNA molecule that targets and kills hormone receptor-positive breast cancer cells without harming healthy tissue. This breakthrough could transform treatment for the 70% of breast cancer patients diagnosed with this type.

The discovery came after seven years of dedicated research by Professors Stacey Edwards and Juliet French. Their study, published in Molecular Cancer, reveals how this previously unknown RNA molecule attacks cancer in two powerful ways.

First, it triggers cancer cells to self-destruct from within. Second, it activates the immune system to recognize and kill the cancer cells, something particularly significant for this type of breast cancer that typically "hides" from immune defenses.

The moment of discovery was unforgettable for the research team. "We saw the cancer cells completely destroyed, while the healthy cells were alive," Professor Edwards said. "We could hardly believe what we were seeing, so we just kept repeating the experiment to be sure the results were real."

For Professor Edwards, this work carries deep personal meaning. Her mother developed breast cancer at 34 when Edwards was just five years old. Though her mother passed away just as Edwards finished her university degree, she knew her daughter was pursuing breast cancer research to help others.

The timing of this discovery matters enormously. While existing hormone-blocking therapies have improved survival rates, up to a third of patients develop drug resistance over time, allowing their cancer to return and spread.

Why This Inspires

This breakthrough represents more than scientific achievement. It shows how persistence and personal motivation can drive world-changing discoveries. Seven years of hitting dead ends, repeating experiments, and refusing to give up led to a moment that could save countless lives.

The potential new therapy could work alone or boost existing immunotherapies that currently fail against this "cold" cancer. The research team is now testing different combinations and developing lipid nanoparticles to deliver the treatment directly into cancer cells.

RNA-based therapies can be developed faster than conventional drugs, as the world witnessed during COVID-19 vaccine development. This means patients might benefit from this discovery sooner than traditional drug timelines would allow.

The RNA molecule belongs to a category once dismissed as "junk DNA." Researchers now understand that these noncoding RNA molecules, making up 98% of our genome, carry out crucial functions like regulating gene expression. This discovery adds to growing evidence that what scientists once overlooked may hold keys to treating our most challenging diseases.

For women with advanced hormone receptor-positive breast cancer who have run out of treatment options, this research offers something precious: hope backed by science.